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Purpose: To identify a disease-causing paired box 6 (PAX6) gene mutation in a Chinese family affected by autosomal
dominant congenital aniridia.
Methods: All participants in the study, including the aniridia family and 100 unrelated senile cataract controls, received
a comprehensive ophthalmic examination. Genomic DNA was extracted from their whole blood. Mutation screen in all
exons and their adjacent splicing junctions of PAX6 was performed by direct sequencing of polymerase chain reaction
(PCR) products. PCR products of heterozygous mutation were further cloned into T-vectors and confirmed by sequencing.
Multiple alignments were performed using ClustalX to compare PAX6 protein sequences among vertebrates. MicroRNA
binding sites were predicted by TargetScan.
Results: A novel heterozygous PAX6 deletion c.1251_1353del103 (p.Pro418Serfs*87) affecting exon 14 and the 3′-
untranslated-region (3′-UTR) was identified in the congenital aniridia family. The mutation was exclusively observed in
all affected family members but not in any unaffected family member or unrelated control. Bioinformatics analysis showed
that the deletion led to remarkable changes of the PAX6 protein, including a frameshift, changes of protein sequence, and
a COOH-terminal extension. Multiple alignments showed that the affected region of PAX6 shared high sequence identity
(100%) among its vertebrate orthologs. The COOH-terminal extension might also affect microRNA binding sites in the
3′-UTR as predicted by TargetScan.
Conclusions: In the current study we reported a novel PAX6 deletion resulting in an abnormal PAX6 COOH-terminal
extension in the Chinese family affected by aniridia. Our findings thus add to the mutation spectrum of PAX6.
Congenital aniridia is a severe eye disease that occurs
with  a  prevalence  of  1  in  64,000–96,000  across  different
human populations [1]. Not only the iris but also the lens, optic
nerve, cornea, anterior chamber, and retina can be affected by
aniridia [2]. About two thirds of aniridia cases are familial,
which are autosomal dominant, and the remaining one third
are sporadic [3].
The majority of mutations in congenital aniridia have
been found in the paired box 6 gene (PAX6) [4]. The gene is
a  member  of  the  paired  box  gene  family.  Encoding  a
transcription  factor,  PAX6  spans  more  than  22  kb  at
chromosome  11p13,  contains  14  exons  and  generates  3
isoforms of transcripts by alternative splicing [5]. The PAX6
protein consists of 3 domains as follows: a paired domain (PD)
in the NH2-terminus, a proline-serine-threonine domain (PST)
in the COOH-terminus and a homeodomain (HD) in-between
[6]. At the present time, the total number of mutations reported
is more than 700 [4]. Most of PAX6 mutations are found in
exons 5–14, causing various severe phenotypes in the eye such
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as aniridia [3,5], cataract [7] and possibly myopia [8-10], all
of which could eventually lead to blindness.
Although PAX6 mutations have been reported in Chinese
[11-27],  disease  phenotypes  vary  among  different  PAX6
mutations.  The  phenotype-genotype  correlation,  which  is
important in the understanding of the disease mechanism,
remains to be further elucidated. In the current study, we
screened all exons and their adjacent splicing junctions in
PAX6 in a Chinese family with severe disease phenotypes
including congenital aniridia and myopia, and identified a
novel 103 bp deletion, which caused a frameshift and an
abnormal COOH-terminal extension at the protein level.
METHODS
Subject  recruitment  and  clinical  examination:  The  family
with congenital aniridia was recruited at the Joint Shantou
International Eye Center, Shantou, China (Figure 1). One-
hundred  senile  cataract  controls  without  aniridia  were
recruited  from  surgical  inpatients  at  the  Hospital.  Visual
acuity, refraction error, intraocular pressure, and slit lamp
examinations  were  performed  and  documented  in  all
participants (clinical details of individual I-2 could not be
obtained  due  to  her  old  age).  Spectral-domain  optical
coherence tomography (Cirrus HD-OCT; Carl Zeiss Meditec,
Inc., Berlin, Germany) was conducted for individual III-2.
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989Color  Doppler  ultrasound  examination  of  the  kidney  for
detection of Wilms’ tumor was performed at the Chaonan
People  Hospital  for  affected  family  members.  Peripheral
blood was collected from 6 members of the family (II-1, II-6,
II-7, III-1, III-2, and III-3) and all senile cataract controls.
Genomic DNA was extracted by using the QIAmp Blood kit
(Qiagen, Hilden, Germany).
This study was approved by the Ethics Committee of
Joint Shantou International Eye Center and was conducted in
accordance with the Declaration of Helsinki. Written consent
was obtained from each participating subject after explanation
of the nature of the study.
Mutation screening: Thirteen pairs of primers (Table 1) for
amplicons  targeting  all  exons  and  their  adjacent  splicing
junctions  in  PAX6  (NCBI  human  genome  build  37.2,
NC_000011  for  gDNA,  NM_001604,  NP_001595),  were
modified from a previously study [21]. The polymerase chain
reaction  (PCR)  amplification  was  performed  using  the
GeneAmp PCR System 9700 (ABI, Foster City, CA) in a 25-
µl mixture containing 1.5 mM MgCl2, 0.2 mM of each dNTP
(Sangon,  Shanghai,  China),  1  U  Taq  DNA  polymerase
(Invitrogen, Carlsbad, CA), 0.2 µM primers and 20 ng of
genomic DNA. Bidirectional sequencing of PCR products
was  performed  using  the  BigDye  Terminator  Cycle
Sequencing v3.1 kit (ABI) and the 3130xl Genetic Analyzer
(ABI).  Haplotyping  was  used  to  confirm  the  mutation
sequence. PCR products of heterozygous mutants were ligated
to  pMD®18-T  vectors  (Takara,  Dalian,  China),  and
subsequently  sequenced  by  the  3130xl  Genetic  Analyzer.
Mutation naming followed the nomenclature recommended
by the Human Genomic Variation Society (HGVS).
Bioinformatics analysis: Sequences of PAX6 orthologs in
other  vertebrate  species  were  retrieved  from  the  NCBI
Reference Sequence database. Multiple alignment of PAX6
orthologs from different vertebrate species was conducted
using ClustalX version 2.0 [28]. MicroRNA targets in the
PAX6 3′-UTR was predicted by TargetScan release 6.0 [29].
RESULTS
Clinical data: As illustrated by Table 2 and Figure 2, four
affected  patients  (II-7,  III-1,  III-2,  and  III-3)  receiving
ophthalmic examination showed similar clinical symptoms,
including  congenital  aniridia,  foveal  hypoplasia,  and
nystagmus  (Figure  2).  Intraocular  hypertension  without
evident glaucoma was also observed (except the youngest
child, III-3). Other clinical features were characterized by
normal corneas and transparent lens. The proband (II-7) had
low visual acuity, and had high myopia with refractive errors
equal to −18 diopters (OD) and −12 diopters (OS). Highly
myopic status indicated by relative elongated eye axial length
was found in the eldest child (III-1; OD: 22.82 mm; OS:
24.10 mm) with regards to his age of 6 years. Myopia was not
observed in the other two children (III-2 and III-3) probably
due  to  their  younger  ages.  Color  Doppler  ultrasound
examination showed that there was no Wilms’ tumor in the
four affected patients.
Mutation analysis: By the means of direct sequencing and
haplotyping,  a  heterozygous  103  bp  deletion  (c.
1251_1353del103, p.Pro418Serfs*87) was identified in all
affected family members, which consisted of part of exon 14
and 3′-UTR (Figure 3 and Figure 4). The mutation was not
found in any unaffected family member or senile cataract
control.  No  other  mutation  was  detected  from  any  other
PAX6 exon in the affected family members. The mutation
caused a frameshift and was predicted to generate proteins
with an abnormal COOH-terminal extension, in which 19
amino acid residues starting from codon 418 were replaced by
a peptide of 86 amino acid residues (Figure 5A). Multiple
alignments  of  PAX6  sequences  from  different  vertebrate
species revealed 100% identity of the deleted region at PAX6
COOH-terminus,  which  suggested  that  it  was  highly
conserved during evolution (Figure 5B). TargetScan analysis
predicted a target site of hsa-miR-365 and another target site
of has-miR-375 at the wild type PAX6 3′-UTR, which was
Figure 1. Pedigree of a Chinese family
with aniridia. Filled squares and circles
denote  affected  males  and  females,
respectively.  Normal  individuals  are
shown as empty symbols. The proband
is indicated by an arrow.
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990converted  into  coding  region  by  the  shifted  open  reading
frame in the mutant (Figure 4).
DISCUSSION
In the current study with a family affected by aniridia, we
identified  a  novel  103  bp  deletion  (c.1251_1353del103,
p.Pro418Serfs*87),  which  generated  a  frameshift  and  a
COOH-terminal extension. The deletion was correlated with
aniridia disease phenotypes in an autosomal dominant pattern,
but did not affect the cornea or lens. These findings suggested
that COOH-terminal extension mutations of PAX6 could also
cause severe aniridia phenotype in the Chinese population,
which was comparable to those reported in Caucasians [10].
In Caucasians it was reported that the most common
PAX6  mutations  were  premature  termination  mutations,
amino  acid  substitutions  and  COOH-terminal  extensions
[10]. There were only limited data of PAX6 COOH-terminal
extension  mutations  reported  in  Chinese  [25].  Therefore,
TABLE 1. PRIMERS USED FOR PCR AND SEQUENCING OF PAX6.
Target Exon ID Primer sequence (5′-3′) Annealing
temperature
(°C)
Product
length (bp)
1a* E1aF AGCTGTGCCCAACTCTAGCC 57 399
  E1aR TTCCATCTTTGTATGCCTCCTT    
1 E1F CGGAGCCGAAAACAAGTG 57 388
  E1R GAGTGTGGGTGAGGGAAGTG    
2 E2F CCACTTCCCTCACCCACAC 60 422
  E2R CTCCTGCGTGGAAACTTCTC    
3 E3F AAGTGGGATCCGAACTTGC 57 349
  E3R CAGCCACCACAGAACTTGC    
4 E4F CAAGCCCCAAAGGGTAGATT 57 286
  E4R CGAAGTCCCAGAAAGACCAG    
5 E5F GGCTGGTGGTCCTGTTGTCCTT 58 441
  E5R GAGGGCGTTGAGAGTGGAG    
6,7 E6–7F AAGCAAGGTCAGCACAAAAATAAATT 64 648
  E6–7R GGAGGAGGTAAAGAGGAGAGAGCATT    
8 E8F TAAGGTTGTGGGTGAGCTGAGATG 66 315
  E8R GGGAGAGTAGGGGACAGGCAAAGG    
9 E9F TTTGGTGAGGCTGTCGGGATATAAT 58 415
  E9R TGCCCAGAGAAATAAAAAGACAGAAA    
10 E10F TTGGTTGGAGGTAATGGGAGTGG 61 334
  E10R TGGCAGCAGAGCATTTAGCAGAC    
11,12 E11–12F GGGGCTGGGCTCGACGTAG 62 438
  E11–12R GCCACCACCAGCCGCACTTA    
13 E13F GGGGCTGTGGCTGTGTGATGT 61 333
  E13R CCCCAGGGACAAGGAAAGCAA    
14 E14F CCAAACATGCAAACAAACAGAGGA 52 570
  E14R TTCCAACTGATATCGTGCCTTCTG    
         *:  This  extra  exon  is  located  at  5′  upstream  of  exon1,  existing  in  another  alternatively  spliced  transcript  variant
         NM_001127612.1 but not in NM_001604.4.
TABLE 2. DEMOGRAPHIC AND CLINICAL DATA OF THE ANIRIDIA FAMILY.
      Ophthalmic anomalies  
Subject* Age
(years)
Gender Complete
aniridia
Foveal
hypoplasia
Nystagmus High
myopia
Congenital
cataract
Ocular
Hypertension
Wilms’
tumor
I-2 71 F + NA NA NA - NA NA
II-7 31 F + + + + - + -
III-1 6 F + + + + - + NA
III-2 5 M + + + - - + -
III-3 2 M + + + NA - - -
         M: male; F: female; NA: not available; * All of the other families members have complete iris, without ocular hypertension or
         high myopia or other major eye diseases, and thus are not listed the table.
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991COOH-terminal extensions of PAX6 in Chinese remained to
be further investigated. The PAX6 deletion found in our study
(c.1251_1353del103)  led  to  a  frameshift,  and  caused  a
COOH-terminal  extension  into  the  3′-UTR
(p.Pro418Serfs*87).  It  also  changed  the  COOH-terminal
amino acid sequence by replacing the last 19 amino acid
residues with a peptide of 86 amino acid residues, and possibly
affected  the  PST  domain  of  PAX6  (Figure  5).  Sequence
analysis showed that the deleted residues in the PST domain
were highly conserved among different vertebrate species
from  Zebrafish  to  humans  (Figure  5),  implicating  its
substantial role in ocular and neurologic development. The
PST domain is a transactivation domain and participates in
modulating  the  DNA  binding  function  of  PAX6  [30-33].
Brain-expressed  proteins  interact  with  PAX6  through  the
COOH-terminus and with the entire PST domain [34]. The
COOH-terminus extension in our Chinese family possibly
disrupted the function of PST domain, and could cause severe
ocular anomalies including aniridia in an autosomal dominant
pattern.
Phenotypic  consequence  in  different  types  of  PAX6
mutations was reported in Chinese aniridia patients [11-27],
but the understanding of that in COOH-terminal extension
mutations remained to be further studied. Previously Zhang
et al. [25] reported a COOH-terminal extension mutation c.
1268A>T  (X423LeuextX*15)  in  aniridia  patients,  but  the
mutation was also found in a patient with cataract and intact
iris, probably due to incomplete penetrance. In Caucasians the
severity of anomalies in COOH-terminal extension mutations
were  comparable  to  that  in  premature  termination  codon
mutations,  including  iris  anomalies,  foveal  hypoplasia,
keratopathy, cataracts and myopia [9,10]. Intriguingly, in our
Chinese aniridia family the mutation had part of the last exon
and the 3′-UTR in PAX6 deleted, and resulted in a COOH-
terminal  extension,  probably  without  triggering  nonsense-
mediated mRNA decay [35]. Among the patients bearing the
mutation,  the  anomalies  included  aniridia,  intraocular
hypertension  and  high  myopia,  although  myopic  status
remained to be confirmed in the two younger children due to
their young ages. If untreated, glaucomatous damage might
also develop in these affected patients. Taken together, these
findings possibly were in line with a suggestive role played
by the PAX6 3′-UTR in myopia etiology. Single nucleotide
polymorphisms in the PAX6 3′-UTR were associated with
myopia  in  Chinese  [36,37].  The  PAX6  3′-UTR  might  be
involved in myopia development by regulating the expression
of  PAX6  mRNAs,  which  was  similar  to  short  repeats  in
PAX6 promoter [8]. Analysis by TargetScan predicted targets
of microRNAs hsa-miR-365 and has-miR-375 encompassed
by the COOH-terminal extension (Figure 4). To date, there
has been no report directly studying the role of microRNA
targeting  PAX6  in  aniridia.  Nevertheless,  microRNAs
targeting other genes in the PAX6 pathway have been reported
to  be  involved  in  eye  development.  For  example,  Meis
Figure 2. Photos and images showing
the clinical features of affected patients.
A:  Complete  absence  of  iris  in  III-2
(OS). B: Foveal hypoplasia observed in
III-2 (OS). C: A flat fovea in III-2 (OS)
demonstrated  by  optical  coherence
tomography.
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992homeobox 2 (MEIS2) modulates PAX6 transcription activity,
and in madaka fish morpholino-mediated ablation of miR-204
targeting Meis2 results in an eye phenotype characterized by
microphthalmia,  abnormal  lens  formation,  and  altered
dorsoventral  patterning  of  the  retina  [38].  Therefore,  the
conversion from microRNA binding sites at the wild type
PAX6 3′-UTR to coding region in the mutant, may abolish the
regulation capacity of has-miR-365 and has-miR-375, and
further  elicit  increased  PAX6  mRNA  expression,  and
consequently aniridia and high myopia. In addition, our data
showed that the mutation did not cause either anomalies in the
cornea or lens, or systemic symptoms in the kidney such as
Wilms’  tumor.  Our  genotype-phenotype  analysis  thus
provided  useful  information  for  understanding  functional
consequences  of  COOH-terminal  extension  mutations  in
PAX6.
Figure 3. Confirmation of the PAX6 deletion in the aniridia family by direct-sequencing. The sequence in the plus strand of chromosome 11
is shown. The upper panel is the chromatogram of the PAX6 wild type, and the lower panel is the chromatogram of the mutant. The arrow
indicates the position of the deletion, and the deleted sequence is shown above the arrow.
Figure 4. Diagram of the human PAX6 gene and the deletion with the consequent COOH-terminal extension in the current aniridia family.
MicroRNA targets are predicted by TargetScan.
Molecular Vision 2012; 18:989-995 <http://www.molvis.org/molvis/v18/a104> © 2012 Molecular Vision
993In the present study, we found a novel PAX6 deletion in
a Chines family affected by congenital aniridia. Our findings
thus  expanded  the  mutation  spectrum  of  PAX6  gene  in
Chinese.
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